GPP estimated value was based solely on the prophylactic results, this was before the Zenith 750 mg positive results came out. I think value is $15 to $20 for HAE alone...let's see the new molecule!
__________________________________
GPP Letter from Feb. 2018 (snippet):
"We believe BCRX's lead product, BCX-7353, alone has a present value of well over $1.5 billion, more than three times the current market capitalization of BCRX."
https://
www.prnewswire.com/news-releases/great-point-partners-llc-opposes-the-biocryst-pharmaceutical-propo
sed-merger-with-idera-pharmaceuticals-inc-300600186.html